Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?

Mult Scler Relat Disord

Center for Translational Neuroscience, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address:

Published: October 2022

During the coronavirus disease 2019 (COVID-19) pandemic, mass vaccination was a beneficial strategy in many countries. Nevertheless, reports of serious complications such as postvaccination neuromyelitis optica spectrum disorder (NMOSD) raised concerns about the safety of vaccines. Anamnart and colleagues explained postvaccination NMOSD following different vaccines, including COVID-19. To emphasize the message of this article, in this letter, we present a unique case of postvaccination NMOSD with a fulminant and fatal course, which may show a plausible relationship between COVID-19 vaccination and triggering anti-aquaporin-4 antibody (AQP4-Ab).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254455PMC
http://dx.doi.org/10.1016/j.msard.2022.104035DOI Listing

Publication Analysis

Top Keywords

neuromyelitis optica
8
optica spectrum
8
spectrum disorder
8
disorder nmosd
8
covid-19 vaccination
8
postvaccination nmosd
8
fulminant neuromyelitis
4
nmosd
4
covid-19
4
nmosd covid-19
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!